In prostate cancer, elevated expression of LSD1 correlates with prostate cancer recurrence and with increased VEGFA expression, and knockdown of LSD1 in prostate cancer cells decreases VEGFA expression [132]. Here, VEGFA is linked to prostate carcinoma.